• Mashup Score: 10

    In patients with prostate cancer who have a high risk of pelvic nodal disease, the use of elective whole pelvis radiotherapy is still controversial. Two large, randomised, controlled trials (RTOG 9413 and GETUG-01) did not show a benefit of elective whole pelvis radiotherapy over prostate-only radiotherapy. In 2020, the POP-RT trial established the role of elective whole pelvis radiotherapy in…

    Tweet Tweets with this article
    • NEW Review in the August issue: Elective #nodal #radiotherapy in #prostatecancer #pcsm https://t.co/Djd8gt71Pr